의료기기용 무균 포장 시장 보고서 : 동향, 예측, 경쟁 분석(-2035년)

Medical Device Sterile Packaging Market

The future of the global medical device sterile packaging market looks promising with opportunities in the primary, secondary, and tertiary markets. The global medical device sterile packaging market is expected to reach an estimated $129.4 billion by 2035 from $69.4 billion in 2027 with a CAGR of 8.1% from 2027 to 2035. The major drivers for this market are the increasing demand for safe treatments, the rising prevalence of chronic diseases, and the growing focus on infection control.

• Lucintel forecasts that, within the type category, tray is expected to witness higher growth over the forecast period due to greater need for more efficient and protective tray-based packaging.
• Within the application category, secondary is expected to witness the highest growth over the forecast period due to rising packaging and product protection and distribution through secondary packaging.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to growth of the packaging industry and consumer goods production in various markets.

Emerging Trends in Medical Device Sterile Packaging Market

The medical device sterile packaging market is shifting from basic barrier protection toward validated, lower-impact systems. Between 2025 and 2027, device complexity, stricter contamination controls, hospital efficiency goals, and resin volatility will reshape material selection. Lucintel expects demand to remain resilient as manufacturers redesign packaging for sustainability without compromising sterility assurance or shelf life.

• Sustainability: In March 2025, EU packaging reforms intensified pressure to reduce unnecessary material and improve recyclability, while healthcare suppliers continued testing paper-based lids and lower-gauge films; packaging can represent up to 30% of a medical device's environmental footprint. This trend will influence specifications, procurement decisions, and supplier qualification throughout the next three to five years.
• Automation: Automated sealing, vision inspection, and digital batch records are moving from large plants into contract packaging operations; FDA-regulated facilities increasingly connect packaging equipment with electronic quality systems to reduce manual release work. Labor shortages and tighter traceability requirements will accelerate investment in automated sterile packaging lines through 2030.
• Smart Materials: Tyvek, coated medical paper, high-barrier films, and breathable membranes are being engineered for demanding devices, including implants and robotic instruments; DuPont reported that Tyvek is used in more than 90% of sterile medical packaging applications globally (2024). Material innovation will support thinner designs while maintaining microbial barrier performance.
• Digital Manufacturing: Additive manufacturing and small-batch device production are increasing demand for flexible packaging formats, shorter validation cycles, and digitally managed artwork; FDA's 2024 final guidance on computer software assurance supports risk-based validation of production systems. This shift will favor converters offering rapid tooling, variable data, and connected quality documentation.
• Regional Supply Chains: Medical device producers are qualifying secondary converters and sourcing closer to assembly sites after freight disruption and resin price swings; North American reshoring investment exceeded $200 billion in announced manufacturing projects during 2023-2024. Regional capacity will reduce supply risk and strengthen demand for qualified local sterile packaging suppliers.

Sterility assurance remains the purchasing priority, but cost, environmental reporting, and production resilience now shape specifications earlier. Suppliers that combine validated barrier performance with automation-ready formats and credible lifecycle data should gain share. The market will reward practical redesign rather than publicity-led sustainability claims, especially where hospitals and regulators demand measurable waste reduction.

Recent Developments in the Medical Device Sterile Packaging Market

The medical device sterile packaging market is consolidating due to increased regulations. This will keep the industry active until at least 2027 as device packaging converters allocate funds for more capacity, device packaging owners adapt their portfolio holdings, and new regulations are enacted for quality and sustainability. Lucintel expects sustained demand for specialized packaging for surgical devices, implants and diagnostics, and combinations of pharmaceutical and device devices.

• Consolidation Through Acquisition: Amcor finalized its purchase of Berry Global of $8.43 billion in April 2025. The new medical device packaging consolidation is expected to allow Amcor to improve its market coverage, purchasing, and ability to invest for the next three to five years. Smaller converters are expected to experience even greater challenges of price competition in the market.
• Enforcement of Quality Systems: The U.S. FDA updated its Quality Management System Regulation in February 2026. The recent changes have brought the U.S. FDA's regulations in line with ISO 13485, meaning on-going device manufacturers will need to adopt more complex quality systems and higher levels of traceability.
• Conversion To Sustainable Materials: The European Union's Packaging and Packaging Waste Regulation eliminated in February 2025, provided more specific guidelines for the design of environmentally friendly packaging. Over the next five years, suppliers will be challenged to decrease material complexity while still maintaining enhancing the sterilization of packaging and the integrity of the packaging seals.
• Increase in Capacity: Medical device packaging suppliers are constructing regional medical device packaging capacity in order to shorten overall supply chain length and support local medical device manufacturing. Nelipak announced in 2025, the expansion of its Costa Rica facility to provide capacity for local device manufacturing and shorter time frames to qualify sterile components.
• Advanced Packaging Automation: Vision inspection, digital process monitoring, and automated seal verification are examples of innovations along the packaging line. Manufacturers say automated inspections significantly reduce the need for manual inspections in 2025. Validation data that is consistent and flexible will drive customer purchases and the subsequent high demand for less defects and quicker decision-making.

2025 to 2027 will see sterile packaging transition from a compliance-led consumable to a manufacturing input. Consolidation leads to larger scale, and both QMSR and European sustainability regulations also increase the validation work. The suppliers of combinatorial recyclable structures with validated barrier performance will gain market share. The hospitals will not accept changes to packaging that affect the sterility, shelf life, or even the reliability of opening, especially in the critical care and surgical parts of the business.

Strategic Growth Opportunities in the Medical Device Sterile Packaging Market

The medical device sterile packaging market is expected to begin in 2024 through 2026. Device complexity combined with more stringent controls on contamination, sustainability goals, and regional manufacturing will alter procurement. Lucintel expects dynamic changes driven by FDA reforms combined with pressures on hospital budgets and developments in packaging to drive market growth. Suppliers integrating the capacity to validate and apply materials science in the service of packaging should experience the greatest growth.

• High-performance Barrier Materials: Sensitive implants and combination products will require high performance barrier materials that protect the device during the shelf life of the product. From 2 February 2026, the FDA will evaluate the performance of barriers against the QMSR (Quality Management System Regulation). This will likely drive procurement toward the suppliers who can validate barrier performance and demonstrate process control.
• Sustainable Sterile Formats: Sterile barriers that are mono-material and made from fiber-based trays may attract fewer sustainability concerns when used in hospitals, without compromising barrier integrity. The Packaging and Packaging Waste Regulation was implemented in the EU in February 2025. Likely over the next three to five years, compliant designs will command a price premium and be successful in winning multinational tenders.
• Convergence of Pharmaceuticals and Medical Devices: Packaging designed for the stability of drug substances needs to also consider the functionality of the medical devices. The FDA approved 48 novel drugs in 2024, creating further demand for combination products. Converting packaging to meet these demands with integrated product and packaging design will further drive industry growth.
• Regional Manufacturers: Regional production of surgical and diagnostic devices will drive demand for packaging that is validated for the region. Exports of medical devices from India exceeded $4.7 billion in fiscal 2024-25. Local technical resources and an approved qualification laboratory will increasingly determine market share in countries outside North America.
• Digital Manufacturing Services: Automated inspection, serialization, and data-linked seal verification can help reduce batch release delays. January 2025 saw the FDA report over 6,000 registered device establishments. This reinforces traceability requirements. Digital services will create a stream of revenue for manufacturers as they connect packaging data with quality systems.

Packaging suppliers with validated materials, regional capacity, and reliable technical support have the edge for the next cycle. Growth will not be from volume growth alone. The stronger proposition offers a lower total cost, documented sterility assurance, and less environmental impact. Buyers will begin to reward partners that engage in the design phase of devices over converters that join in the later stages after the specifications are fixed.

Medical Device Sterile Packaging Market Drivers and Challenges

medical device sterile packaging market

The medical device sterile packaging market is influenced by healthcare needs, economic factors, sustainability, and demands and changes in technology and public policy. An increased focus on sterilization in combination with the increased number of medical procedures will drive market expansion. However, rising costs of materials, supply chain issues, and environmental factors will challenge market expansion. According to Lucintel, the key market differentiators for packaging will be innovation and regulatory compliance.

Factors impacting medical device sterile packaging market include:

• Increased Number of Medical Procedure: An increase in surgery and chronic illness, an aging population, and increased access to healthcare necessitates an increased demand for medical device sterile packaging. Healthcare facilities will need packaging that maintains sterility for implantable devices, surgical tools, sterilized single use tools, and other medical devices throughout the entire packaging and distributive process. In 2025, the World Health Organization reported that 43 million deaths were due to a variety of chronic illnesses and diseases in 2021, adding further demand and need for chronic illness to be managed and treated. Increased demand for medical packaging will also be influenced by healthcare facilities' budgets, regulations, and reimbursements for elective surgeries.
• Technological Innovation: Packaging technology is improving due to advanced films and membranes, the use of thermoformed trays, intelligent indicators, and new sealing technologies. Moving beyond the current options available, these technologies help manufacturers create packaging with better sterility, puncture resistance, and ease of use, as well as providing visibility. The FDA Quality Management System Regulation, which the FDA published in February 2026, is a regulation that published more formal guidance on validated and documented processes. This regulation is expected to shift the economic landscape of the packaging and manufacturing industry with the advent of automated, digital, and data enabled packaging inspection technologies within the next 3 to 5 years. Manufacturers will prioritize technologies that offer consistent quality and a quick time to market.
• Regulatory Compliance: Within the U.S., the FDA is widening the scope of its Quality Management System Regulation, effective February 2026, to mirror more of the requirements of ISO 13485:2016. This is leading to increased obligations for documented evidence of compliance, which will lead to demand for validated materials and services. There is already a demand for controlled environments for manufacturing and testing. Due to the stringent requirements, device manufacturers will have to engage with specialized packaging to achieve biocompatibility, sterilization, seal integrity, shelf life, and transport verification. This will reduce recalls, contamination, and litigation. In the next 3 to 5 years, smaller companies will incur more costs
• Sustainability and Material Innovation: Healthcare providers and equipment producers now actively pursue designs that utilize less material and have an ability to incorporate more sustainable, less wasteful material and fiber choices. The potential is substantial due to the multifaceted nature of sterilization packaging that must maintain an appropriate balance of protection, barrier, sterilization, and shelf life. The recently enacted Packaging and Packaging Waste Regulation of the European Union, which will take effect on February 11, 2025, will strengthen the long-term requirements for sustainability of packaging. Within the next three to five years, a packaging solution with verified, sustainable, or recyclable, or fiber-based packaging done at a competitive price will have a greater opportunity to be accepted, while the sustainability innovations of packaging will be evaluated on the infrastructure of recycling, the cost, and the assurance of no compromise of patient safety.
• Manufacturing Efficiency and Cost Optimization: The constant evolution of the packaging industry in terms of design, manufacturing, and systems integration will yield significant improvements on material utilization and reduce variability relative to packaging systems. This packaging systems manufacturing evolution will allow medical device manufacturers to control pricing,

This Market faces the following challenges:

• Raw Material Cost Volatility: Sterile packaging uses medical-grade polymers, specialty papers, adhesives, coatings, and aluminum requiring increasingly energy-intensive processes. Costs can vary due to crude oil pricing, energy pricing, and regional limitations. With the demand for oil still exceeding 100 million barrels a day as of 2025, it can be expected that polymer supply lines will still be affected by the energy market. Over the coming three to five years, the cost of medical-grade polymers is expected to reflect the volatility of polymers and energy. Lightweighting and the use of recycled or substitute materials will be more appealing, though more difficult. Because of the qualifications for medical-grade materials, supplier diversification and planning will be necessary. Furthermore, contracts of longer duration will be required.
• Strict Validation and Compliance Requirements: Changes in packaging require extensive testing and evaluation of the new packaging's performance as a barrier to microbial ingress and its seal strength and suitability for storage, transport, and sterilization. Assessment of the new packaging's ease of use also has to be determined. The required labs must be specialized and controlled, and the processes and documentation must be coordinated between packaging, sterilization, quality and regulatory personnel. With the FDA Quality Management System Regulation becoming
• Sustainability Trade Offs and Recycling Limitations: In order to meet performance demands, the sterile packaging of medical devices often relies on multi-layered, multi-material structures that are difficult, if not impossible, to recycle. While designs that prioritize the use of recyclable, renewable, and biodegradable materials may help lower the environmental impact of sterile packaging, there are other trade-offs such as compromised barrier properties, seals that are not as strong, less effective sterilization, and potentially a reduced shelf life. The European Union's new Packaging and Packaging Waste Regulations, in effect as of February 11, 2025, will require a significant number of new legislation driven packaging design solutions. The next three to five years will be dominated by a highly challenging, uncoordinated patchwork of regional design and recycling regulations. During this time, design and packaging solutions geared to meet these regulations will be expensive, difficult to implement, and will have significant uncertainty regarding the validity of sustainability claims.

The sterile packaging market will increase in conjunction with the evolution of medical devices, which in turn will be driven by new trends in surgical procedures, new regulations, increased complexities, and the need for better infection control. Innovation driven by an increased focus on improved design of better performing sterile packaging will be accelerated by advances in technology and manufacturing. These innovations will allow for a decrease in the cost of sterile packaging by decreasing the waste generated during the manufacturing process. Shift in materials, increased cost pressure, regulatory tradeoffs, and unstable recycling solutions will constrain efforts to innovate. Suppliers combining the above attributes with eco-friendly materials will have the best prospects. Overall, market development and progress will be contingent on finding a workable trade off in a complex supply chain between safety, cost, and reliably meeting sterile barrier requirements, and an environmentally sustainable solution that satisfies the needs of the market.

List of Medical Device Sterile Packaging Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies medical device sterile packaging market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the medical device sterile packaging market companies profiled in this report include-

• 3M
• DuPont
• Amcor
• Sonoco
• Catalent
• Printpack
• Berry Plastics
• West Pharmaceutical Services
• Klockner Pentaplast
• Technipaq

Medical Device Sterile Packaging Market by Segment

The study includes a forecast for the global medical device sterile packaging market by type, application, and region.

Medical Device Sterile Packaging Market by Type [Value ($B) from 2019 to 2035]:

• Trays
• Pouches
• Others

Medical Device Sterile Packaging Market by Application [Value ($B) from 2019 to 2035]:

• Primary
• Secondary
• Tertiary

Medical Device Sterile Packaging Market by Region [Value ($B) from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Medical Device Sterile Packaging Market

The medical device sterile packaging market is within a new regulatory and supply chain environment. Leading up to 2027, manufacturers are more interested in validated materials, increasing domestic capacity, and adjusting to changing quality standards. Based on Lucintel's newest report, all of these changes are altering the large-scale production market.

• United States: In February 2026, the FDA's Quality Management System Regulation will take effect and help manufacturers comply more closely with ISO 13485, and in September 2025, DuPont made plans to expand its Luxembourg Tyvek medical-packaging facility by 6,000 tons. Both of these changes may affect the medical-packaging industry in different ways, but each should bolster demand for documented and validated sterile-barrier systems.
• China: The NMPA continues to create their medical-device regulatory system and promotes domestic substitution; in June 2025, another manufacturing and research facilities within Shanghai subsidiary MicroPort continued to be financed. For the upcoming changes to the regulatory environment, this policy and investment direction will greatly assist domestic qualification of sterile packaging for high volume production of both implantable and disposable devices.
• Germany: SCHOTT Pharma is investing in their pharmaceutical and medical-packaging manufacturing with their announced €370 million investment to be completed by 2028. This greatly enhances Europe's manufacturing capacity for specialized glass and container components, securing Germany's place in regulated packaging's supply chains for the next three to five years.
• India: The Indian government has local manufacturing initiatives that are further supported by Poly Medicure's increment in production in Haryana. The firm expended ₹127 crore in fiscal 2025. More local production of medical devices should help Indian suppliers of sterile-pouch, tray and thermoformed packaging to be recognized and qualified.
• Japan: Terumo will continue to invest in production capacity in Japan as well as overseas for its portfolio of catheters, syringes, and other sterile devices. The investment for fiscal 2025 is ¥1.03 trillion. Its high level of production and manufacturing will help maintain demand for high integrity packaging and automated inspection technologies.

Features of the Global Medical Device Sterile Packaging Market

• Market Size Estimates: medical device sterile packaging market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
• Segmentation Analysis: medical device sterile packaging market size by type, application, and region in terms of value ($B).
• Regional Analysis: medical device sterile packaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the medical device sterile packaging market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the medical device sterile packaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the medical device sterile packaging market by type (trays, pouches, and others), application (primary, secondary, and tertiary), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 6 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Medical Device Sterile Packaging Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Trays: Trends and Forecast (2019-2035)
• 4.4 Pouches: Trends and Forecast (2019-2035)
• 4.5 Others: Trends and Forecast (2019-2035)

5. Global Medical Device Sterile Packaging Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Primary: Trends and Forecast (2019-2035)
• 5.4 Secondary: Trends and Forecast (2019-2035)
• 5.5 Tertiary: Trends and Forecast (2019-2035)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Medical Device Sterile Packaging Market by Region

7. North American Medical Device Sterile Packaging Market

• 7.1 Overview
• 7.2 North American Medical Device Sterile Packaging Market by Type
• 7.3 North American Medical Device Sterile Packaging Market by Application
• 7.4 United States Medical Device Sterile Packaging Market
• 7.5 Mexican Medical Device Sterile Packaging Market
• 7.6 Canadian Medical Device Sterile Packaging Market

8. European Medical Device Sterile Packaging Market

• 8.1 Overview
• 8.2 European Medical Device Sterile Packaging Market by Type
• 8.3 European Medical Device Sterile Packaging Market by Application
• 8.4 German Medical Device Sterile Packaging Market
• 8.5 French Medical Device Sterile Packaging Market
• 8.6 Spanish Medical Device Sterile Packaging Market
• 8.7 Italian Medical Device Sterile Packaging Market
• 8.8 United Kingdom Medical Device Sterile Packaging Market

9. APAC Medical Device Sterile Packaging Market

• 9.1 Overview
• 9.2 APAC Medical Device Sterile Packaging Market by Type
• 9.3 APAC Medical Device Sterile Packaging Market by Application
• 9.4 Japanese Medical Device Sterile Packaging Market
• 9.5 Indian Medical Device Sterile Packaging Market
• 9.6 Chinese Medical Device Sterile Packaging Market
• 9.7 South Korean Medical Device Sterile Packaging Market
• 9.8 Indonesian Medical Device Sterile Packaging Market

10. ROW Medical Device Sterile Packaging Market

• 10.1 Overview
• 10.2 ROW Medical Device Sterile Packaging Market by Type
• 10.3 ROW Medical Device Sterile Packaging Market by Application
• 10.4 Middle Eastern Medical Device Sterile Packaging Market
• 10.5 South American Medical Device Sterile Packaging Market
• 10.6 African Medical Device Sterile Packaging Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Medical Device Sterile Packaging Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 3M
  • Company Overview
  • Medical Device Sterile Packaging Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 DuPont
  • Company Overview
  • Medical Device Sterile Packaging Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Amcor
  • Company Overview
  • Medical Device Sterile Packaging Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Sonoco
  • Company Overview
  • Medical Device Sterile Packaging Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Catalent
  • Company Overview
  • Medical Device Sterile Packaging Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Printpack
  • Company Overview
  • Medical Device Sterile Packaging Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Berry Plastics
  • Company Overview
  • Medical Device Sterile Packaging Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 West Pharmaceutical Services
  • Company Overview
  • Medical Device Sterile Packaging Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Klockner Pentaplast
  • Company Overview
  • Medical Device Sterile Packaging Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Technipaq
  • Company Overview
  • Medical Device Sterile Packaging Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us